Literatur
Zentrum für Krebsregisterdaten, Robert-Koch Institut, Stand 2012. http://www.krebsdaten.de/Krebs/DE/Content/Krebsarten/Brustkrebs/brustkrebs_node.html. Zugriffszeitpunkt: 14. Sept. 2016
World Health Organization cancer fact sheet 02/2015. [On-line] http://www.who.int/mediacentre/factsheets/fs297/en/index.html. Zugriff: 16. Sept. 2016
Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65:5–29
Jemal A, Siegel R, Ward E et al (2006) Cancer statistics, 2006. CA Cancer J Clin 56:106–130
Goldhirsch A, Glick JH, Gelber RD et al (2005) Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 16:1569–1583
Brewster AM, Hortobagyi GN, Broglio KR et al (2008) Residual risk of breast cancer recurrence 5 years after adjuvant therapy. J Natl Cancer Inst 100:1179–1183
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Darby S, McGale P et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: metaanalysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378:1707–1716
Glendenning J, Cook G (2013) Imaging breast cancer bone metastases: current status and future directions. Semin Nucl Med 43:317–323
Goss PE, Ingle JN, Martino S et al (2003) A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 349:1793–1802
Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. Juli 2012. AWMF-Register-Nummer: 032 – 045OL.
Pan L, Han Y, Sun X et al (2010) FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysis. J Cancer Res Clin Oncol 136:1007–1022
Xu G, Zhao L, He Z (2012) Performance of whole-body PET/CT for the detection of distant malignancies in various cancers: a systematic review and meta-analysis. J Nucl Med 53:1847–1854
Cheng G, Torigian DA, Zhuang H et al (2013) When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET? Eur J Nucl Med Mol Imaging 40:779–787
Hildebrandt MG, Gerke O, Baun C, Falch K et al (2016) 18 F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography(CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy. J Clin Oncol 34:1889–1897
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M. Avanesov und T. Derlin geben an, dass kein Interessenkonflikt besteht.
Rights and permissions
About this article
Cite this article
Avanesov, M., Derlin, T. Multimodale Bildgebung des Mammakarzinomrezidivs. Radiologe 57, 1–3 (2017). https://doi.org/10.1007/s00117-016-0182-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00117-016-0182-y